Search Results 221-230 of 52849 for heart failure
... heart failure (HF) outcomes and HF quality-of-care metrics. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
The purpose of this study is to determine the long-term outcome of cardiac resynchronization therapy (CRT) recipients with congestive heart failure and any ...
Blood clot in the lungs (pulmonary embolism) · Heart attack (myocardial infarction) · Heart structure problems that are present at birth (congenital heart defects) ...
At diagnosis, some people may have no symptoms, while others may already have severe heart failure. Our doctors have access to the latest tests and ...
... cardiac biomarkers, and were at increased risk of heart attack, congestive heart failure, stroke and other adverse cardiovascular events. According to the ...
Stem cell therapies. Clinical studies have shown that stem cells are not only safe, but can be effective treatment options for patients with heart disease.
Heart failure. This is the most serious complication of large arteriovenous fistulas. Blood flows more quickly through an arteriovenous fistula than it does ...
A Study to Evaluate Heart Failure Biomarker to Predict Cardiomyopathy After Acute Radiation · Overview · Participation eligibility · Participating Mayo Clinic ...
If untreated, it may lead to heart failure or death in extreme cases. ... Inflammation of the pericardium following a heart attack or after heart surgery or a ...
About this study. Heart failure with reduced ejection (HFrEF) is a major health concern. HFrEF is associated with significant endothelial dysfunction (ED).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.